ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 116 filers reported holding ALX ONCOLOGY HLDGS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,936 | -36.1% | 19,570 | 0.0% | 0.02% | -35.3% |
| Q2 2023 | $146,971 | +66.1% | 19,570 | 0.0% | 0.03% | +61.9% |
| Q1 2023 | $88,457 | -59.9% | 19,570 | 0.0% | 0.02% | -61.1% |
| Q4 2022 | $220,554 | +17.9% | 19,570 | 0.0% | 0.05% | +5.9% |
| Q3 2022 | $187,000 | +18.4% | 19,570 | 0.0% | 0.05% | +21.4% |
| Q2 2022 | $158,000 | -52.3% | 19,570 | 0.0% | 0.04% | -44.0% |
| Q1 2022 | $331,000 | -21.4% | 19,570 | 0.0% | 0.08% | -13.8% |
| Q4 2021 | $421,000 | -70.9% | 19,570 | 0.0% | 0.09% | -71.8% |
| Q3 2021 | $1,445,000 | +35.0% | 19,570 | 0.0% | 0.31% | +34.3% |
| Q2 2021 | $1,070,000 | -50.2% | 19,570 | 0.0% | 0.23% | -51.8% |
| Q1 2021 | $2,149,000 | – | 19,570 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $530,392,000 | 62.60% |
| Logos Global Management LP | 3,156,981 | $172,624,000 | 14.51% |
| Vivo Capital, LLC | 4,220,048 | $230,752,000 | 9.99% |
| Foresite Capital Management V, LLC | 231,200 | $12,642,000 | 4.97% |
| Cormorant Asset Management, LP | 889,454 | $48,635,000 | 1.65% |
| Board of Trustees of The Leland Stanford Junior University | 259,982 | $14,216,000 | 1.33% |
| Redmile Group, LLC | 914,035 | $49,979,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 192,728 | $10,538,000 | 0.71% |
| Financial Advisory Group | 54,041 | $2,955,000 | 0.71% |
| Nan Fung Group Holdings Ltd | 34,950 | $1,911,000 | 0.59% |